A.D.A.M.

An on-demand personalized implant manufacturing infrastructure

A.D.A.M.

An on-demand personalized implant manufacturing infrastructure

Stamford, CT
Biotechnology
A.D.A.M. develops an on-demand personalized implant manufacturing infrastructure with a full scope of related services, provided remotely or on site.

$96,345

raised
90
Investors
$30.8M
Valuation
$2.93
Price per Share
$293.00
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

$96,345

raised
90
Investors
$30.8M
Valuation
$2.93
Price per Share
$293.00
Min. Investment
Preferred
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
Reg CF
Offering

Rewards

Get rewarded for investing more into A.D.A.M.:

$293+
Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$500+
Investment
Tier 1: $500+
Invest $500+ and receive 2%
$1,000+
Investment
Tier 2: $1,000
Invest $1,000+ and receive 3%
$2,500+
Investment
Tier 3: $2,500+
Invest $2,500+ and receive 5%
$5,000+
Investment
Tier 4: $5,000+
Invest $5,000+ and receive 10%

Reasons to Invest

Disrupt a growing market: The orthopedic implants market is expected to reach $79.5 billion in 2030.
Support innovation: A.D.A.M. leading the way in orthopaedics implant production with 3D printing methods.
Improve production times: Competitors in the implant industry have an average 2-4 weeks delivery time, while we are aiming to offer 1-3 day delivery.

OVERVIEW


Implant manufacturing, one 3D print at a time

A.D.A.M. (Advanced Development of Additive Manufacturing) is a developer of an on-demand personalized implant manufacturing infrastructure with a full scope of related services, provided remotely or on site.  


Currently in the Research and Development stage, A.D.A.M. is designing for medical professionals to complete all steps of the implant printing process from 3D-modeling to receiving a sterilized personalized device, ready for implantation. As a pre-revenue company, A.D.A.M. has identified potential growth opportunities in the orthopaedic surgery, oncology, and CMF, neuro-, and plastic surgery markets.


The company has developed MVP for its printer, materials, digital platform, and has a Quality Management System in place. The company is about to start the animal trials as per the FDA requirements.



THE PROBLEM


Implants are costly and invasive

Many professionals are rethinking global healthcare models due to COVID-19. The basic demand for materials (such as human tissue and organs) remains largely unmet due to supply chain vulnerabilities. The orthopaedic market is currently dominated by titanium implants, which are costlyhave long delivery times, are rarely personalized to the needs of the patients, and typically require a second surgery to extract internal metal fixation.


*Images are computer generated demo versions. Product is still currently under development.

THE SOLUTION


Bone implants made from 3D printing methods

A.D.A.M.’s platform consists of bone implants, printers, materials, digital platform, and our Quality Management System. We create 3D bone implants from ceramic bio-glass for flat bone implants using a Binder Jetting Printing (BJP) method. For tubular bone implants, we use modified biopolymer with a Fused Filament Fabrication (FFF) printing method. The overall production time for us to develop a 3D implant will take up to 24 hours.


*Image is computer generated demo versions. 


Our process


1. Implant modeling: Patients or healthcare providers upload and securely store MRI and CAT scans on our digital platform.  



2. Implant production: Certified clinicians use the platform to create a 3D model of the implant based on the patient's medical data.



3. Implantation: Medical professionals receive a sterilized 3D printed bone implant ready for use and a set of Quality Management System procedures.



4. Recovery: There is no need for reoperation to extract implant elements. Our bone implants are biodegradable, stimulate osteogenesis, and are fully replaced by the bone tissue over time.


THE MARKET


Disrupting a market over $47 billion

Our target markets are orthopaedic surgery, oncology, and CMF, neuro-, and plastic surgery. The orthopaedic implants market is estimated at $47 billion for 2019, and expected to reach $79.5 billion in 2030 due to an aging population and an augmented incidence of orthopaedic diseases.



Based on our internal research, competitors in the implant industry have long delivery times of at least 2 to 4 weeks on average, whereas we plan to offer 1-3 day delivery. We are able to keep production costs low because of our material composites and 3D printing methods.



Most competitors offer implants made of either biopolymer or bioceramic implants, while we offer both. The market leader OPM does not offer biodegradable materials at all.


OUR TRACTION


FDA clearance by 2022

In August 2020, FDA confirmed 510(k) eligibility for A.D.A.M. biopolymer and bioceramic bone implants. We have 4 provisional patents (2 for materials and 2 for printers) in the U.S., along with 2 patents for materials in Ukraine.


A.D.A.M. plans to complete the animal studies required by the FDA in 2022. No human trials are required. FDA clearance is expected in late 2022 - early 2023.



OUR ADVISORY BOARD



A.D.A.M prides ourselves on the established team of advisors we have put together. Our Advisory Board consists of top minds in orthopaedics, material science and 3D printing, chemistry, innovations development, business and digital strategy. 


With calibre of people such as former DARPA director, a top strategy advisor for Secretary of Defense and NATO, to name a few, we are collectively ready to disrupt the health care and 3D printing industry on a scale.




WHY INVEST


A path to growth

A.D.A.M.’s product has unique characteristics that we believe no other company in the industry has. Bone implants are just the beginning - in the years to come A.D.A.M. aims to launch R&D of blood vessel implants, heart valves, and bronchial implants.

*Image is computer generated demo versions. 




Insert Video

In the Press

Entering Altered Carbon: A.D.A.M. – Developers of Personalized Implant Printing

Science fiction and Hollywood TV series are becoming a reality thanks to Ukrainian technology startups such as A.D.A.M., which helps customers print new organs, bones, or tissue on a 3D printer.

A First Look at 3D Printed Bioresorbable Bone Implants From A.D.A.M.

A.D.A.M. is on the cusp of releasing 3D printed bioresorbable bone implants. The implants would, if successful, be completely absorbed by the body. Recovery times would improve; patients would undergo fewer surgeries; the implant is personalized to each patient.

FDA Confirms 510(K) Eligibility for Biotech Company A.D.A.M. – 3D Printed Bones Are to Become a Reality in Less Than 2 Years

In recent months, Global healthcare system problems have become strikingly evident. The outbreak of COVID-19 has exacerbated existing issues in the industry, causing many professionals to rethink the healthcare models currently in place.

Farmington startup developing 3D-printed bone implants

If all goes according to plan, healthcare facilities in the next few years could begin purchasing 3D-printed bone implants that are being developed by a Farmington-based startup called A.D.A.M.

And the Winners of Startup Grind’s First Ever Global Pitch Battle Are…

Startup Grind hosted its first-ever virtual Global Pitch Battle Competition in late September 2020 where startups from all around the world battled it out to win amazing prizes, global recognition, and of course, bragging rights.

Offering Summary


Company

:

Advanced Development of Additive Manufacturing, Inc.

Corporate Address

:

9 W Broad St, Suite 320H, Stamford, CT 06902

Offering Minimum

:

$9,997.16

Offering Maximum

:

$1,069,994.98

Minimum Investment Amount

(per investor)

:

$293.00











Terms


Offering Type

:

Equity

Security Name

:

Series A Preferred Stock

Minimum Number of Shares Offered

:

3,412

Maximum Number of Shares Offered

:

365,186

Price per Share

:

$2.93

Pre-Money Valuation

:

$30,788,952.80











Please refer to the Company Securities section of the Offering Memorandum for further details regarding the Series A Preffered Stock rights for the securities sold in this offering.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives and Bonuses*

Time-Based:

Friends and Family Early Birds

Invest within the first 72 hours and receive additional 15% bonus shares.

 

Super Early Bird Bonus

Invest within the next 72 hours and receive additional 10% bonus shares.

 

Early Bird Bonus

Invest within the next 7 days and receive an additional 5% bonus shares.

Amount-Based:

$500+

Perk: 2% Bonus Shares

$1000+

Perk: 3% Bonus Shares

$2,500+

Perk: 5% Bonus Shares

$5,000+

Perk: 10% Bonus Shares

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Advanced Development of Additive Manufacturing, Inc.'s will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Series A Preferred Stock at $2.93 / share, you will receive 110 Series A Preferred Stock, meaning you'll own 110 shares for $293. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Inter company debt or back payments. Vendor payments. Salary payments made to one’s self, a friend or relative.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$77,745.00 USD
$1,364.00 USD
Cash And Cash Equivalents
$4,069.00 USD
$1,364.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$128,661.00 USD
$120.00 USD
Long Term Debt
$0.00 USD
$0.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$92,736.00 USD
-$90.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Notice of Funds Disbursement

5 hours ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, A.D.A.M. has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in A.D.A.M. be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Happy International 3D Printing Day!

10 hours ago

Happy International 3D Printing Day! Held on 3 December (3D..), this year marks 30 years since the invention of the first 3D printer. It’s amazing to consider the progress that has been made in that time, leading to current day innovations such as;

  • A 3D printer orbiting the Earth on the International Space Station, acting as an on-demand manufacturing workspace

  • Printed ‘meat’, including Waygu beef

  • Designs ranging from large scale entirely printed houses, to tiny elements for robots

  • Biodegradable bone implants

Speaking of bone implants...! To mark the day we're happy to share some behind the scenes snaps from the Research & Development lab; whilst these structures may look like building blocks at the beach, they are actually printed test samples. The scaffold structures are part of development research analyzing different internal structures. Pictured during the process; R&D Project Manager Michael Pluzhnik. 

These prints are just a few from a number of samples currently being tested. A.D.A.M. are working with a number of globally recognized universities and medical establishments on several exciting and promising projects. To find out more about these partnerships become an investor today, and be part of the future of healthcare. 




 

A.D.A.M. CEO to be guest panelist in additive manufacturing forum for US Government

2 days ago

CEO Denys Gurak has been invited to speak at a high profile forum organised by the Additive Manufacturing Coalition. 

A.D.A.M. has been in ongoing discussions with the US Department of Defence and Veterans Administration, as they are looking to implement 3D printing in healthcare as one of the primary technologies for treatment of wounded soldiers. As a result of this professional relationship, Mr. Gurak has been invited to speak on a panel by the Additive Manufacturing Coalition. The Coalition is an NGO working to educate the US government on the benefits AM brings to the economy overall, with healthcare bookmarked as one of the primary sectors potentially benefiting from AM.

The upcoming healthcare event is a live online forum Breakthrough Medical Applications of Additive Manufacturing, scheduled for Tuesday December 7th at 3pm EDT. Attendance is open to all interested people and registration is free. If you'd like to listen in to what will be a very interesting panel, RSVP here; https://www.addmfgcoalition.org/events

Mr. Gurak will be joined on the panel by Dr. Matthew Di Prima (Materials Scientist, Food and Drug Administration), Ms. Alyssa Glennon (Principal Engineer, Materialise), and Mr. Gaurav Manchanda (Director of Medical Market Development, Formlabs). 


As A.D.A.M. continues to gain industry and public recognition, now is the time to join our team of investors. 

Competition Finalist and a Podcast: recent highlights for A.D.A.M.

12 days ago

Last month we were thrilled to be a finalist in the Cool Part Showcase; a competition for 3D printed items in the additive manufacturing industry. We were one of four finalists in the Best Proof-of-Concept category with the entry of our Humerus Bone Head - a printed bone implant for the upper arm. 

Being a finalist, the part was on display at the Additive Manufacturing Conference + Expo, where people could see and feel the implant in person. Whilst we didn't take home the win (decided by public vote), it was an honor to be included, and many valuable conversations were sparked.  

Another benefit from being a finalist? We were discussed on the Additive Manufacturing Radio podcast! The episode discusses themes from the Conference, including supply chains, diversity, and disruption (that's us!). An interesting listen for anyone keen to learn about the immediate future of the AM industry. (We're brought up at 20:30 if you'd like to skip ahead). Available on all podcast platforms and link here.

With the industry recognizing us as disruptors to take note of, now is the time to join us as an investor.

 

TV Feature: A.D.A.M. the subject of a dedicated special news report!

14 days ago

It was an exciting day in the R&D lab a couple of weeks ago when the production crew from 1+1 (one of Ukraine's largest TV networks) came to film a special news report about A.D.A.M. The 1+1 network approached us to share our journey to date as a biotech success story, and the special feature recently aired nationally across Ukraine. 

Featuring a behind-the-scenes look at what happens in the lab, CEO Denys Gurak, R&D Project Manager Michael Pluzhnik, and Head of R&D Arkadii Bohdan, MD share their insights. You can even see the 3D printers in action!

This was an independent editorial piece, and not sponsored in any way. To become part of A.D.A.M.'s continuing success story, join our team of investors now. 


A.D.A.M. named by The Economist in '22 Emerging Technologies To Watch in 2022'

17 days ago

We are delighted to share that The Economist has included A.D.A.M. in their feature 'What next? 22 emerging technologies to watch in 2022' - https://www.economist.com/the-world-ahead/2021/11/08/what-next-22-emerging-technologies-to-watch-in-2022

3D-printed bone implants

For years, researchers have been developing techniques to create artificial organs using 3d printing of biological materials. The ultimate goal is to take a few cells from a patient and create fully functional organs for transplantation, thus doing away with long waiting-lists, testing for matches and the risk of rejection.

That goal is still some way off for fleshy organs. But bones are less tricky. Two startups, Particle3d and adam, hope to have 3d-printed bones available for human implantation in 2022. Both firms use calcium-based minerals to print their bones, which are made to measure based on patients’ ct scans. Particle3d’s trials in pigs and mice found that bone marrow and blood vessels grew into its implants within eight weeks. adam says its 3d-printed implants stimulate natural bone growth and gradually biodegrade, eventually being replaced by the patient’s bone tissue. If all goes well, researchers say 3d-printed blood vessels and heart valves are next.


We did not know ahead of time we were being included, so it was a fantastic surprise to be featured in such a globally respected publication. 


2022 will certainly be a big year for A.D.A.M. - now is the perfect time to join us on this path. 

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}